Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure approval for treating locally advanced or metastatic non-small cell lung ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

Medical experts who’ve studied the experimental treatment program, however, say there’s no evidence to support Trump’s claims ...

If Kevin Roberts, the author of the extreme conservative Project 2025 “blueprint” for a second Trump term, is granted an ...

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients aged ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

Scientific inquiry is unpredictable, and the data collected today might need to answer unforeseen questions tomorrow. Rigid ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...